Baidu
map

Thyroid:甲状腺功能正常人群A-FABP水平升高与甲状腺激素敏感性降低有关

2020-05-22 MedSci原创 MedSci原创

在甲状腺正常的人群中,血清A-FABP水平升高与对甲状腺激素的敏感性降低有关,这表明A-FABP可能介导了脂肪组织与甲状腺系统之间的交互作用。

血清脂肪细胞脂肪酸结合蛋白(A-FABP)和甲状腺激素与代谢异常密切相关。但是,它们之间的关系仍然未知。近日,甲状腺疾病领域权威杂志Thyroid上发表了一篇研究文章,研究人员旨在调查血清A-FABP水平与甲状腺功能单个和复合指标之间的关联。

该研究纳入了上海地区1057名社区甲状腺功能正常参与者(年龄范围:27-81岁),其中女性为601名。研究人员通过电化学发光免疫测定法测定了血清游离三碘甲状腺素(FT3)、游离甲状腺素(FT4)和甲状腺刺激激素(TSH),并计算了甲状腺反馈分位数指数(TFQI)、促甲状腺激素指数(TSHI)和促甲状腺激素细胞-T4抵抗指数(TT4RI),以评估对甲状腺激素的中枢敏感性。研究人员通过FT3与FT4的比率(FT3/FT4)评估了甲状腺激素的外周敏感性,并采用酶联免疫吸附测定法测量血清A-FABP水平。

所有受试者的血清A-FABP水平均值为6.41(95%置信区间:6.10-6.74)ng/ml。在多元线性回归分析和多重Logistic回归分析(非常规)调整了多个心血管代谢危险因素。在男女性中,血清A-FABP水平与FT4(男性:标准化β=0.150,P=0.001;女性:标准化β=0.218,P<0.001)、TFQI(男性:标准化β=0.119,P=0.009;女性:标准化β=0.165,P<0.001)和TSHI(男性:标准化β=0.108,P=0.017;女性:标准化β=0.114,P=0.005)呈正相关,而与FT3/FT4呈负相关(男性:标准化β=-0.122,P=0.008;女性:标准化β=-0.129,P=0.001)。血清A-FABP水平与FT3、TSH或TT4RI无关。与TFQI为第一个四分位数组相比,女性A-FABP每增加10 ng/ml,TFQI处于第三个四分位数组女性的比值比为2.213(P=0.035);TFQI处于第四个四分位数组的比值比男性为2.614(P=0.022),女性为3.425(P=0.002)。

由此可见,在甲状腺正常的人群中,血清A-FABP水平升高与对甲状腺激素的敏感性降低有关,这表明A-FABP可能介导了脂肪组织与甲状腺系统之间的交互作用。

原始出处:

Xiaomin Nie,et al.Increased serum adipocyte fatty acid-binding protein levels are associated with decreased sensitivity to thyroid hormones in euthyroid population.Thyroid.2020.https://www.liebertpub.com/doi/10.1089/thy.2020.0011

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1798706, encodeId=472f1e9870667, content=<a href='/topic/show?id=931a6988817' target=_blank style='color:#2F92EE;'>#甲状腺激素敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69888, encryptionId=931a6988817, topicName=甲状腺激素敏感性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Sat Oct 31 22:58:40 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024630, encodeId=9d7520246300f, content=<a href='/topic/show?id=657e162858' target=_blank style='color:#2F92EE;'>#A-FABP水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1628, encryptionId=657e162858, topicName=A-FABP水平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Wed Sep 02 18:58:40 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043673, encodeId=be1d20436e375, content=<a href='/topic/show?id=9185162e32' target=_blank style='color:#2F92EE;'>#A-FABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1627, encryptionId=9185162e32, topicName=A-FABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Sat Oct 24 13:58:40 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009049, encodeId=1c54200904921, content=<a href='/topic/show?id=f8a369865df' target=_blank style='color:#2F92EE;'>#甲状腺功能正常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69865, encryptionId=f8a369865df, topicName=甲状腺功能正常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Jun 04 08:58:40 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049835, encodeId=6a25204983532, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1768, encryptionId=4a5f1e68a9, topicName=ABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Thu Feb 25 17:58:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388508, encodeId=a410138850844, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sun May 24 11:58:40 CST 2020, time=2020-05-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1798706, encodeId=472f1e9870667, content=<a href='/topic/show?id=931a6988817' target=_blank style='color:#2F92EE;'>#甲状腺激素敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69888, encryptionId=931a6988817, topicName=甲状腺激素敏感性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Sat Oct 31 22:58:40 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024630, encodeId=9d7520246300f, content=<a href='/topic/show?id=657e162858' target=_blank style='color:#2F92EE;'>#A-FABP水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1628, encryptionId=657e162858, topicName=A-FABP水平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Wed Sep 02 18:58:40 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043673, encodeId=be1d20436e375, content=<a href='/topic/show?id=9185162e32' target=_blank style='color:#2F92EE;'>#A-FABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1627, encryptionId=9185162e32, topicName=A-FABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Sat Oct 24 13:58:40 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009049, encodeId=1c54200904921, content=<a href='/topic/show?id=f8a369865df' target=_blank style='color:#2F92EE;'>#甲状腺功能正常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69865, encryptionId=f8a369865df, topicName=甲状腺功能正常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Jun 04 08:58:40 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049835, encodeId=6a25204983532, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1768, encryptionId=4a5f1e68a9, topicName=ABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Thu Feb 25 17:58:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388508, encodeId=a410138850844, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sun May 24 11:58:40 CST 2020, time=2020-05-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1798706, encodeId=472f1e9870667, content=<a href='/topic/show?id=931a6988817' target=_blank style='color:#2F92EE;'>#甲状腺激素敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69888, encryptionId=931a6988817, topicName=甲状腺激素敏感性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Sat Oct 31 22:58:40 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024630, encodeId=9d7520246300f, content=<a href='/topic/show?id=657e162858' target=_blank style='color:#2F92EE;'>#A-FABP水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1628, encryptionId=657e162858, topicName=A-FABP水平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Wed Sep 02 18:58:40 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043673, encodeId=be1d20436e375, content=<a href='/topic/show?id=9185162e32' target=_blank style='color:#2F92EE;'>#A-FABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1627, encryptionId=9185162e32, topicName=A-FABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Sat Oct 24 13:58:40 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009049, encodeId=1c54200904921, content=<a href='/topic/show?id=f8a369865df' target=_blank style='color:#2F92EE;'>#甲状腺功能正常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69865, encryptionId=f8a369865df, topicName=甲状腺功能正常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Jun 04 08:58:40 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049835, encodeId=6a25204983532, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1768, encryptionId=4a5f1e68a9, topicName=ABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Thu Feb 25 17:58:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388508, encodeId=a410138850844, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sun May 24 11:58:40 CST 2020, time=2020-05-24, status=1, ipAttribution=)]
    2020-10-24 aids213
  4. [GetPortalCommentsPageByObjectIdResponse(id=1798706, encodeId=472f1e9870667, content=<a href='/topic/show?id=931a6988817' target=_blank style='color:#2F92EE;'>#甲状腺激素敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69888, encryptionId=931a6988817, topicName=甲状腺激素敏感性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Sat Oct 31 22:58:40 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024630, encodeId=9d7520246300f, content=<a href='/topic/show?id=657e162858' target=_blank style='color:#2F92EE;'>#A-FABP水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1628, encryptionId=657e162858, topicName=A-FABP水平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Wed Sep 02 18:58:40 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043673, encodeId=be1d20436e375, content=<a href='/topic/show?id=9185162e32' target=_blank style='color:#2F92EE;'>#A-FABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1627, encryptionId=9185162e32, topicName=A-FABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Sat Oct 24 13:58:40 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009049, encodeId=1c54200904921, content=<a href='/topic/show?id=f8a369865df' target=_blank style='color:#2F92EE;'>#甲状腺功能正常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69865, encryptionId=f8a369865df, topicName=甲状腺功能正常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Jun 04 08:58:40 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049835, encodeId=6a25204983532, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1768, encryptionId=4a5f1e68a9, topicName=ABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Thu Feb 25 17:58:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388508, encodeId=a410138850844, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sun May 24 11:58:40 CST 2020, time=2020-05-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1798706, encodeId=472f1e9870667, content=<a href='/topic/show?id=931a6988817' target=_blank style='color:#2F92EE;'>#甲状腺激素敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69888, encryptionId=931a6988817, topicName=甲状腺激素敏感性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Sat Oct 31 22:58:40 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024630, encodeId=9d7520246300f, content=<a href='/topic/show?id=657e162858' target=_blank style='color:#2F92EE;'>#A-FABP水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1628, encryptionId=657e162858, topicName=A-FABP水平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Wed Sep 02 18:58:40 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043673, encodeId=be1d20436e375, content=<a href='/topic/show?id=9185162e32' target=_blank style='color:#2F92EE;'>#A-FABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1627, encryptionId=9185162e32, topicName=A-FABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Sat Oct 24 13:58:40 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009049, encodeId=1c54200904921, content=<a href='/topic/show?id=f8a369865df' target=_blank style='color:#2F92EE;'>#甲状腺功能正常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69865, encryptionId=f8a369865df, topicName=甲状腺功能正常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Jun 04 08:58:40 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049835, encodeId=6a25204983532, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1768, encryptionId=4a5f1e68a9, topicName=ABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Thu Feb 25 17:58:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388508, encodeId=a410138850844, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sun May 24 11:58:40 CST 2020, time=2020-05-24, status=1, ipAttribution=)]
    2021-02-25 wleon8895
  6. [GetPortalCommentsPageByObjectIdResponse(id=1798706, encodeId=472f1e9870667, content=<a href='/topic/show?id=931a6988817' target=_blank style='color:#2F92EE;'>#甲状腺激素敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69888, encryptionId=931a6988817, topicName=甲状腺激素敏感性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Sat Oct 31 22:58:40 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024630, encodeId=9d7520246300f, content=<a href='/topic/show?id=657e162858' target=_blank style='color:#2F92EE;'>#A-FABP水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1628, encryptionId=657e162858, topicName=A-FABP水平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Wed Sep 02 18:58:40 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043673, encodeId=be1d20436e375, content=<a href='/topic/show?id=9185162e32' target=_blank style='color:#2F92EE;'>#A-FABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1627, encryptionId=9185162e32, topicName=A-FABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Sat Oct 24 13:58:40 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009049, encodeId=1c54200904921, content=<a href='/topic/show?id=f8a369865df' target=_blank style='color:#2F92EE;'>#甲状腺功能正常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69865, encryptionId=f8a369865df, topicName=甲状腺功能正常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Jun 04 08:58:40 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049835, encodeId=6a25204983532, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1768, encryptionId=4a5f1e68a9, topicName=ABP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Thu Feb 25 17:58:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388508, encodeId=a410138850844, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sun May 24 11:58:40 CST 2020, time=2020-05-24, status=1, ipAttribution=)]

相关资讯

Stroke:强化血压治疗可降低白蛋白尿患者的卒中风险

由此可见,在对SPRINT进行事后分析中,基线蛋白尿(相对于无蛋白尿)与发生卒中的风险较高相关,但这种关系似乎仅限于标准治疗组。需要进一步的研究来最终确定降低蛋白尿本身是否有利于降低卒中风险。

NEJM:心血管疾病患者的脂蛋白(a)降低策略

由此可见,在脂蛋白(a)水平升高并确诊为心血管疾病的患者中,APO(a)-LRx以剂量依赖性方式降低脂蛋白(a)水平。

NEJM:CT筛查降低了肺癌死亡率

由此可见,在这项涉及高危人群的试验中,进行了CT筛查的个体肺癌死亡率显著低于未进行筛查的个体。

Brit J Surg:减肥手术在降低结直肠癌风险中的作用

由此可见,与不进行手术的肥胖患者相比,进行减肥手术的患者发生结直肠癌的风险降低了35%。

ESC2019:坏胆固醇和血压只低一点点,日积月累也会有大作用

英国剑桥大学Brian Ference在ESC2019年学术会议上报告,血压和胆固醇对于心血管病有累加作用,呈现剂量依赖性,这有点像类似计算吸烟的“吸烟年数×包”的概念。

Eur Heart J:未治疗的高血压患者基于导管的肾脏去神经支配术后动态心率降低

由此可见,与假手术患者相比,RDN患者的平均和最小早晨HR在3个月时显著降低。高于中位数的基线24小时HR可预测更大程度的血压降低,并且可以允许医生选择可能对该手术有反应的患者。

Baidu
map
Baidu
map
Baidu
map